Febuxostat for the Management of Hyperuricaemia in Patients with Gout: A NICE Single Technology Appraisal
Year of publication: |
2011
|
---|---|
Authors: | Stevenson, Matt ; Pandor, Abdullah |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 29.2011, 2, p. 133-140
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Allopurinol | therapeutic use | Cost-effectiveness | Febuxostat | Formularies | Gout | treatment | Hyperuricaemia |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Advances in Cancer Therapeutics and Patient Access to New Drugs
Dranitsaris, George, (2011)
-
Bagust, Adrian, (2010)
-
Alitretinoin for Severe Chronic Hand Eczema: A NICE Single Technology Appraisal
Rodgers, Mark, (2010)
- More ...
-
Bevacizumab for Metastatic Colorectal Cancer
Whyte, Sophie, (2012)
-
Bevacizumab for Metastatic Colorectal Cancer: A NICE Single Technology Appraisal
Whyte, Sophie, (2012)
-
Tosh, Jonathan, (2013)
- More ...